Steris (STE) Tops Q2 EPS by 2c; provides outlook

Steris (NYSE: STE) reported Q2 EPS of $2.03, $0.02 better than the analyst estimate of $2.01. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.3 billion.

GUIDANCE:

The company is confirming its outlook for fiscal 2024 of as reported revenue growth of 9-10% and constant currency organic revenue growth of 6-7% vs. estimated growth of 9.74% Y/Y.

Steris sees FY2024 EPS of $8.60-$8.80, versus the consensus of $8.75.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c